Abrogation of anti-HLA antibodies via proteasome inhibition. - Wikidata - wikimedia - TriplyDB

Abrogation of anti-HLA antibodies via proteasome inhibition.

Abrogation of anti-HLA antibodies via proteasome inhibition.

http://www.wikidata.org/entity/Q33384617

about

Current state of renal transplant immunosuppression: Present and future Role of T cell-nuclear factor κB in transplantation Biologics in renal transplantation Modern approaches to incompatible kidney transplantation Treatment options and strategies for antibody mediated rejection after renal transplantation The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports Bortezomib use in a pediatric cardiac transplant center.How we approach an acquired thrombotic thrombocytopenic purpura patient.Pediatric heart transplantation-indications and outcomes in the current era.B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Bortezomib in kidney transplantation.Immunosuppression in kidney transplantation.Antibody-mediated rejection: an evolving entity in heart transplantation.Antibody-mediated rejection in kidney transplantation: a review Challenges and considerations in diagnosing the kidney disease in deteriorating graft function.Increased C4d in post-reperfusion biopsies and increased donor specific antibodies at one-week post transplant are risk factors for acute rejection in mild to moderately sensitized kidney transplant recipients.Report from a consensus conference on antibody-mediated rejection in heart transplantation Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study.Advances in diagnosing and managing antibody-mediated rejection.Noninvasive methods to assess the risk of kidney transplant rejection.Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.Current immunosuppressive treatment after kidney transplantation.Antibody-mediated rejection in kidney transplantation: an update.New therapeutic approaches to antibody-mediated rejection in renal transplantation.Emerging drugs for the treatment of transplant rejection.Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.Proteasome inhibitors: an expanding army attacking a unique target.Cardiac antibody-mediated rejection.Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.Clinical relevance of antibody development in renal transplantation.Novel immunosuppressive agents in kidney transplantation Advances in pharmacotherapy to treat kidney transplant rejection.Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity.Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.Successful Kidney Transplantation After Stepwise Desensitization Using Rituximab and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible High Titer Patient B-cell tolerance in transplantation: is repertoire remodeling the answer?Outcomes of combination therapy for chronic antibody-mediated rejection in renal transplantation.Acute antibody-mediated rejection in pediatric kidney transplants: a single center experience.Antibody-mediated rejection: pathogenesis, prevention, treatment, and outcomes.

P2860

Q26829789-34FE3B8D-DC95-482B-8C3A-422C6D0AFA28 Q26852416-497C9F56-CC67-4AE1-A12A-18FC392DD0C6 Q27009997-36CC734B-C67D-4F02-A83E-5F4CA877CFF4 Q27010224-C1D9966F-BF90-4493-8079-606A594E8374 Q27021397-A21A4CDA-143F-4C8C-85A4-A790C31393DC Q28478144-B5585338-A64A-4482-9E49-1B9A50A084AA Q33389918-29136E1E-5F1D-4F6E-98CD-5C36958D974B Q33415926-6ECC3297-C89B-49C1-BCA3-2039C8C55128 Q33416780-4BB5A8DD-68F1-40AA-9568-B6E104721705 Q34048053-2706543B-C37F-4D16-B7F1-1D3E6703F4E5 Q34159016-2B1E5722-04BA-48D4-944D-7C788B4A26C6 Q34189435-EFEA2961-1274-492A-9EAD-BF27F8181D54 Q35714310-BBF6D13F-351D-4227-888F-61E41E668B86 Q35876250-38FA8A04-9291-463E-B148-C8B8AF9A6F3A Q35915453-20F96C5B-FA20-4BEC-8BB7-E34070225BB9 Q36365811-5F7662D5-2FAD-420A-BC21-919DC9D4F04C Q36901669-8CEB219F-412D-43B3-A8AD-1D4F0029F823 Q37313051-8E704FF2-CEFA-4420-B5A0-31AD4A7133D0 Q37361071-61C3704E-F3CD-4DB2-9A04-0C54C672EF32 Q37676032-C7A8AF4D-FB1A-4FC0-86BE-CE417935E606 Q37693693-0B53A813-8275-4D4A-A36B-58C80C2BD01A Q37833902-93DAF3E4-BF83-4282-B740-EE797AA59D81 Q37834028-FED714B1-61F8-4B78-9D33-1A8601687A64 Q37835834-99644F8D-39D0-475F-898B-ADF0C2387858 Q37898509-1038BEC6-1EA6-433C-8C42-D7C7B5986A9A Q37960177-78CD864B-34EB-45C3-A656-5D35865D7215 Q37966118-26AD2789-995E-4186-82DF-FB87C4D4B5D1 Q37979388-EF41DBF9-8C00-4119-950C-2C1D9659722F Q38002449-101AE2B2-1D84-4B0F-8A0F-7FE4271598E5 Q38032621-B483CF52-AD17-4357-99DF-6F8A47FDDFD1 Q38079301-AAD28670-E08A-48B7-B248-043AC3D671FE Q38176005-39B51DBB-F35B-433B-941B-261F3C07F27D Q38544529-8E669A54-F2D7-4E1D-A939-C7450A05174E Q38644746-F7EDAD26-3CED-475B-9FA6-E1E4E855A89A Q39716270-54A9790B-063A-4A8E-8724-19BBEC1EE2EB Q41596280-4EE99A0C-D887-47B0-BF0E-899015B2DDFE Q42038591-1A159B75-41E7-44B0-9A2C-5EAEA568AC73 Q42247863-C945DD5A-B603-4364-A1F8-D75DE3079C5B Q42280145-8ED0031D-209E-4D4A-961D-D1A5D9BA3CD0 Q42553965-21B82E74-8A18-4EA6-A62E-D8A1A3F86487

P2860

Abrogation of anti-HLA antibodies via proteasome inhibition.

http://www.wikidata.org/entity/Q33384617

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Abrogation of anti-HLA antibodies via proteasome inhibition.

@ast

Abrogation of anti-HLA antibodies via proteasome inhibition.

@en

type

label

Abrogation of anti-HLA antibodies via proteasome inhibition.

@ast

Abrogation of anti-HLA antibodies via proteasome inhibition.

@en

prefLabel

Abrogation of anti-HLA antibodies via proteasome inhibition.

@ast

Abrogation of anti-HLA antibodies via proteasome inhibition.

@en

P1433

Q33384617-0550F36E-2DF3-4732-A751-0361BD93A893

P1476

Q33384617-0F6D9575-887B-48B6-8F93-CD2DBAF39923

P2093

Q33384617-0DD520EC-4651-4591-8DF6-133CFC5F923E

Q33384617-351CBD21-0196-45CF-802C-00D4CA3457EC

Q33384617-7E986B73-0B4D-42AD-A0C1-65BE4E0CC088

Q33384617-803A7158-23E6-4F2A-A286-073033E4ECFB

Q33384617-85901090-1859-4F0F-8478-3EA92BE6E830

Q33384617-978EA495-ABE2-44BD-B0D0-1382572E06C2

Q33384617-B81C274B-C7F9-436A-96D3-73984521165B

Q33384617-B9272430-54D9-4E91-B186-5231A4F705B8

Q33384617-C2FC8B1A-984C-4FF5-B193-37F67C87EFBC

Q33384617-DDE9BC80-8A8B-40C4-9D02-2B6CBAFABEB3

P304

Q33384617-1867F055-CC8C-40B7-BF93-7A3C1F9656BB

P31

Q33384617-56F563FD-CFF6-4C33-8CB4-772399F68F58

P356

Q33384617-14C025D6-3CA8-444F-B0AC-D059FF15F094

P433

Q33384617-3D652AAF-4E00-4534-B269-4FD71F0D7486

P478

Q33384617-EF6A9C1E-4289-4A83-B4DC-0097BC762664

P50

Q33384617-0A45E70E-9434-4CC2-972A-F0EDC9F77621

Q33384617-8E70A1B6-D06B-4AEE-96BC-5B7ACEBC764B

P577

Q33384617-C837360A-C9B9-41CF-A784-8875A3C1365D

P698

Q33384617-A1ED4C50-412C-4DDB-AB85-D798E5F2FD83

P921

Q33384617-62E0C288-9B8A-466C-83C3-E039FB5C9A32

P356

TP.0B013E3181A4B91B

P1433

Transplantation

P1476

Abrogation of anti-HLA antibodies via proteasome inhibition.

@en

P2093

Adam K Idica

http://www.w3.org/2001/XMLSchema#string

Aruna V Vanikar

http://www.w3.org/2001/XMLSchema#string

Aziz Feroz

http://www.w3.org/2001/XMLSchema#string

Hargovind L Trivedi

http://www.w3.org/2001/XMLSchema#string

Matthew J Everly

http://www.w3.org/2001/XMLSchema#string

Paul I Terasaki

http://www.w3.org/2001/XMLSchema#string

Sajani I Khemchandani

http://www.w3.org/2001/XMLSchema#string

Shruti D Dave

http://www.w3.org/2001/XMLSchema#string

Vangipurapu Shankar

http://www.w3.org/2001/XMLSchema#string

Varsha B Trivedi

http://www.w3.org/2001/XMLSchema#string

P304

1555-1561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3181A4B91B

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Pranjal R. Modi

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19461494

http://www.w3.org/2001/XMLSchema#string

P921